James C. Lin
Lawyers
Filters
Interra Acquisition HK$1 billion IPO
We advised the SPAC on its IPO and HKEX listing
InSilico Medicine $35 million Series D2 financing
We are advising InSilico Medicine on the financing
China Railway $500 million guaranteed bonds offering
The guaranteed bonds are due 2027
InSilico Medicine $60 million Series D financing
We are advising InSilico Medicine in connection with its $60 million Series D financing
PT Freeport Indonesia $3 billion notes offering
We advised the issuer on its Rule 144A / Regulation S notes offering
WT Microelectronics $190 million global depository shares offering
The GDSs represent common shares listed on the Taiwan Stock Exchange
Provident Acquisition $1.02 billion combination with Perfect
We are advising Provident Acquisition, a SPAC, on the transaction
Carsome Group $290 million Series E funding round
We are advising Carsome on its Series E funding round
BeiGene RMB22.2 billion Shanghai IPO
The offering, equivalent to $3.5 billion, is the largest biotech IPO to date in 2021
CANbridge Pharmaceuticals HK$685 million IPO
We advised CANbridge Pharmaceuticals on its IPO and HKEX listing